How much, and by what mechanisms, does growth hormone replacement improve the quality of life in GH-deficient adults? (Q33542806)

27 July 2017

1 reference

title

How much, and by what mechanisms, does growth hormone replacement improve the quality of life in GH-deficient adults? (English)

1 reference

27 July 2017

1 reference

Chrisoulidou A

1

1 reference

27 July 2017

Kousta E

2

1 reference

27 July 2017

Beshyah SA

3

1 reference

27 July 2017

Robinson S

4

1 reference

27 July 2017

Johnston DG

5

1 reference

27 July 2017

publication date

1 July 1998

1 reference

Bailliere's clinical endocrinology and metabolism

27 July 2017

published in

1 reference

27 July 2017

volume

12

1 reference

27 July 2017

issue

2

1 reference

27 July 2017

page(s)

261-279

1 reference

Overnight metabolic fuel deficiency in patients treated conventionally for hypopituitarism.

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980022-0

7 January 2021

A comprehensive psychopathological rating scale

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980022-0

7 January 2021

Development of a novel scale to assess life fulfillment as part of the further refinement of a quality-of-life model for epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980022-0

7 January 2021

Replacement treatment with biosynthetic human growth hormone in growth hormone-deficient hypopituitary adults

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980022-0

7 January 2021

Effect of growth hormone on brain neurotransmitters

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980022-0

7 January 2021

Quality of life in adults with growth hormone (GH) deficiency: response to treatment with recombinant human GH in a placebo-controlled 21-month trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980022-0

7 January 2021

Growth hormone treatment affects brain neurotransmitters and thyroxine [see comment]

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980022-0

7 January 2021

Quality of life in short adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980022-0

7 January 2021

The effects of two doses of replacement growth hormone on the biochemical, body composition and psychological profiles of growth hormone-deficient adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980022-0

7 January 2021

The importance of growth hormone in the regulation of erythropoiesis, red cell mass, and plasma volume in adults with growth hormone deficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980022-0

7 January 2021

Intellectual performance after presymptomatic cranial radiotherapy for leukaemia: effects of age and sex.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980022-0

7 January 2021

The Australian Multicenter Trial of Growth Hormone (GH) Treatment in GH-Deficient Adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980022-0

7 January 2021

Cognitive changes during growth hormone replacement in adult men.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980022-0

7 January 2021

Cognitive impairments and mood disturbances in growth hormone deficient men.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980022-0

7 January 2021

Growth hormone replacement does not improve psychological well-being in adult hypopituitarism: a randomized crossover trial

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980022-0

7 January 2021

The impact of long-term therapy by a multidisciplinary team on the education, occupation and marital status of growth hormone deficient patients after termination of therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980022-0

7 January 2021

A comparison of two psychiatric screening tests

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980022-0

7 January 2021

Growth hormone (GH) immunoreactivity in the rodent and primate CNS: distribution, characterization and presence posthypophysectomy.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980022-0

7 January 2021

Characteristics of adults who wish to enter a trial of growth hormone replacement.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980022-0

7 January 2021

Factors influencing the desire for long-term growth hormone replacement in adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980022-0

7 January 2021

A quantitative approach to perceived health status: a validation study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980022-0

7 January 2021

Measuring the impact of epilepsy: the development of a novel scale

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980022-0

7 January 2021

Treatment of growth hormone-deficient adults with recombinant human growth hormone increases the concentration of growth hormone in the cerebrospinal fluid and affects neurotransmitters

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980022-0

7 January 2021

Characterization of putative growth hormone receptors in human choroid plexus.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980022-0

7 January 2021

Quality of life assessment before and after growth hormone treatment in adults with growth hormone deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980022-0

7 January 2021

Psychological well-being before and after growth hormone treatment in adults with growth hormone deficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980022-0

7 January 2021

A New Depression Scale Designed to be Sensitive to Change

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980022-0

7 January 2021

Growth hormone and its receptors in the central nervous system--location and functional significance

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980022-0

7 January 2021

An account of the quality of life of patients after treatment for non-functioning pituitary tumours.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980022-0

7 January 2021

Quality of life in patients with Addison's disease: effects of different cortisol replacement modes

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980022-0

7 January 2021

Impaired social status of growth hormone deficient adults as compared to controls with short or normal stature

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980022-0

7 January 2021

Neuropsychological effects of cranial radiation: current knowledge and future directions

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980022-0

7 January 2021

Decreased psychological well-being in adult patients with growth hormone deficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980022-0

7 January 2021

Growth hormone deficiency and replacement in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980022-0

7 January 2021

The diagnosis of growth hormone deficiency in children and adults

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980022-0

7 January 2021

The reliability of reporting adverse experiences

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980022-0

7 January 2021

Clomipramine treatment of obsessive-compulsive disorder. I. A controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980022-0

7 January 2021

The brief scale for anxiety: a subdivision of the comprehensive psychopathological rating scale

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980022-0

7 January 2021

Two years of replacement therapy in adults with growth hormone deficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980022-0

7 January 2021

The development, reliability and validity of a disease specific quality of life model for adults with growth hormone deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980022-0

7 January 2021

Quality of life, body composition and muscle strength in adult growth hormone deficiency: the influence of growth hormone replacement therapy for up to 3 years.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980022-0

7 January 2021

Growth hormone treatment of adults with growth hormone deficiency: results of a 13-month placebo controlled cross-over study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980022-0

7 January 2021

10.1016/S0950-351X(98)80022-0

Identifiers

DOI

1 reference

27 July 2017

1 reference